A1BG and melanoma: Comparing significant increased proteins of patients with stage IV melanoma that were shared with significantly increased proteins in baseline samples of nonresponding stage III patients with recurrent disease revealed an overlap for leucine-rich alpha-2-glycoprotein 1 (LRG1), alpha-1B glycoprotein (A1BG), and complement factor/component (Fig. 2B–D).